The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AMERISOURCEBERGEN CORP | COM | 03073E105 | 13,985,758 | 84,399 | SH | SOLE | 84,399 | 0 | 0 | ||
AEGLEA BIO THERAPEUTICS INC | COM | 00773J103 | 1,351,931 | 3,004,959 | SH | SOLE | 3,004,959 | 0 | 0 | ||
ASLAN PHARMACEUTICALS LTD | ADS | 04522R101 | 457,473 | 1,270,758 | SH | SOLE | 1,270,758 | 0 | 0 | ||
AVANTOR INC | COM | 05352A100 | 5,272,500 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | 20,229,380 | 683,425 | SH | SOLE | 683,425 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 3,483,675 | 555,610 | SH | SOLE | 555,610 | 0 | 0 | ||
CIGNA CORP | COM | 125523100 | 17,432,129 | 52,611 | SH | SOLE | 52,611 | 0 | 0 | ||
CAREMAX INC | COM CL A | 14171W103 | 112,205 | 30,741 | SH | SOLE | 30,741 | 0 | 0 | ||
CAREMAX INC | *W EXP 06/08/202 | 14171W103 | 6,692 | 12,808 | SH | SOLE | 12,808 | 0 | 0 | ||
CONNECT BIOPHARMA HOLDINGS LTD | ADS | 207523101 | 518,665 | 597,678 | SH | SOLE | 597,678 | 0 | 0 | ||
CTI BIOPHARMA CORP | COM | 12648L601 | 1,983,300 | 330,000 | SH | SOLE | 330,000 | 0 | 0 | ||
QUEST DIAGNOSTICS INC | COM | 74834L100 | 14,392,480 | 92,000 | SH | Put | SOLE | 92,000 | 0 | 0 | |
ELEVATION ONCOLOGY INC | COM | 28623U101 | 341,744 | 359,731 | SH | SOLE | 359,731 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQUISITION CORP. | UNIT 10/23/2027 | G3141W114 | 2,481,767 | 248,674 | SH | SOLE | 248,674 | 0 | 0 | ||
FUSION PHARMACEUTICALS INC | COM | 36118A100 | 820,411 | 260,448 | SH | SOLE | 260,448 | 0 | 0 | ||
HEALTH SCIENCES ACQUISITIONS CORP 2 | ORD SHS | G4411D109 | 2,495,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
HESKA CORP | COM RESTRC NEW | 42805E306 | 5,240,647 | 84,309 | SH | SOLE | 84,309 | 0 | 0 | ||
HUMACYTE INC | *W EXP 08/27/202 | 44486Q103 | 20,314 | 49,998 | SH | SOLE | 49,998 | 0 | 0 | ||
ICON PLC | SHS | G4705A100 | 6,601,198 | 33,983 | SH | SOLE | 33,983 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 1,271,900 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
INOGEN INC | COM | 45780L104 | 5,650,699 | 286,692 | SH | SOLE | 286,692 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 1,849,824 | 86,400 | SH | Put | SOLE | 86,400 | 0 | 0 | |
MERRIMACK PHARMACEUTICALS INC | COM NEW | 590328209 | 2,865,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
MOLECULIN BIOTECH INC | COM | 60855D200 | 1,099,064 | 1,036,853 | SH | SOLE | 1,036,853 | 0 | 0 | ||
MEDTRONIC PLC | SHS | G5960L103 | 9,948,160 | 128,000 | SH | SOLE | 128,000 | 0 | 0 | ||
MODULAR MEDICAL INC | COM NEW | 60785L207 | 1,378,704 | 689,352 | SH | SOLE | 689,352 | 0 | 0 | ||
MEDICUS SCIENCES ACQUISITION | CL A SHS | G5960S108 | 23,392,610 | 2,323,000 | SH | DFND | 2,323,000 | 0 | 0 | ||
MERUS NV | COM | N5749R100 | 1,360,633 | 87,953 | SH | SOLE | 87,953 | 0 | 0 | ||
NEOLEUKIN THERAPEUTICS INC | COM | 64049K104 | 19,501 | 38,312 | SH | SOLE | 38,312 | 0 | 0 | ||
NOVAVAX INC | COM NEW | 670002401 | 3,495,200 | 340,000 | SH | SOLE | 340,000 | 0 | 0 | ||
NEXTCURE INC | COM | 65343E108 | 183,300 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
NYXOAH SA | SHS | B6S7WD106 | 80,389 | 16,110 | SH | SOLE | 16,110 | 0 | 0 | ||
ORGANON & CO | COMMON STOCK | 68622V106 | 16,418,259 | 587,836 | SH | SOLE | 587,836 | 0 | 0 | ||
PHARVARIS NV | COM | N69605108 | 3,206,250 | 285,000 | SH | SOLE | 285,000 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 4,741,868 | 434,635 | SH | SOLE | 434,635 | 0 | 0 | ||
REATA PHARMACEUTICALS INC | CL A | 75615P103 | 2,545,330 | 67,000 | SH | Put | SOLE | 67,000 | 0 | 0 | |
RELMADA THERAPEUTICS INC | COM | 75955J402 | 821,895 | 235,500 | SH | SOLE | 235,500 | 0 | 0 | ||
RELMADA THERAPEUTICS INC | COM | 75955J402 | 822,244 | 235,600 | SH | Put | SOLE | 235,600 | 0 | 0 | |
PROMETHEUS BIOSCIENCES INC | COM | 74349U108 | 63,162,000 | 574,200 | SH | Put | SOLE | 574,200 | 0 | 0 | |
SIENTRA INC | COM | 82621J105 | 517,395 | 2,550,000 | SH | SOLE | 2,550,000 | 0 | 0 | ||
STAAR SURGICAL CO | COM PAR $0.01 | 852312305 | 7,627,042 | 157,129 | SH | SOLE | 157,129 | 0 | 0 | ||
SAVARA INC | COM | 805111101 | 1,342,994 | 866,448 | SH | SOLE | 866,448 | 0 | 0 | ||
TYRA BIOSCIENCES INC | COM | 90240B106 | 1,156,408 | 152,159 | SH | SOLE | 152,159 | 0 | 0 | ||
UNITED THERAPEUTICS CORP | COM | 91307C102 | 15,283,548 | 54,959 | SH | SOLE | 54,959 | 0 | 0 | ||
VINCERX PHARMA INC | COM NEW | 92731L106 | 104,090 | 102,049 | SH | SOLE | 102,049 | 0 | 0 | ||
VANDA PHARMACEUTICALS INC | COM | 921659108 | 1,007,442 | 136,325 | SH | SOLE | 136,325 | 0 | 0 | ||
X4 PHARMACEUTICALS INC | COM | 98420X103 | 1,813,181 | 1,825,963 | SH | SOLE | 1,825,963 | 0 | 0 |